BN Business News
Add your company to Business Communicator →

Energy & environment · 26/10/20261 min read

Opinion/decision on a Pediatric Investigation Plan (PIP): Bylvay, odevixibat sesquihydrate, type of decision: PM: Decision on the application for modification of an agreed PIP, therapeutic area: Hepatobiliary disorders;Gastroentology-Hepatology, PIP number: EMA/PE/0000240317

Summary

Opinion/decision on a PIP: Bylvay, odevixibat sesquihydrate, type of decision: PM: decision on the application for modification of an agreed PIP, therapeutic area: Hepatobiliary disorders;...

Original source language: EMA — Paediatric Investigation PlansOpen original release →

Explore insights

Business insights →